Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”PPTA Europe’s visits with members and stakeholders this past year were a powerful reminder of why our work matters.
Seeing operations up close, meeting teams, walking through facilities and donation centres, and hearing real-world experiences, grounds our policy and advocacy efforts in the realities you navigate every day.
These moments of connection bring clarity to our mission and reinforce the importance of working together.
The insights gained during these visits strengthened connections and sparked new ideas for how we can collectively advance our shared goals.
Building on this momentum is a priority for 2026.
If you are interested in hosting a visit, send me a note.
These in-person exchanges deepen understanding, amplify collaboration, and help ensure our work reflects the needs and experiences of our members.
Let’s make 2026 a year of stronger connections and meaningful progress across our community.
Connected, we are stronger!”

Stay updated with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera
-
Nov 19, 2025, 15:43Mohannad G Abdelgader: Understanding Thrombosis – Silent But Serious
